WELLINGTON MANAGEMENT GROUP LLP
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$296,269,646
-$77,894,083 QoQ
Shares Held
8,157,204
+1.5% QoQ
Ownership
7.74%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 87.57506861419672.ToString("F0")%
None 12.424931385803273.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,771 across 180 Biotechnology names. CRNX ranks #18 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in CRNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $296,269,646 | 8,157,204 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $374,163,729 | 8,037,889 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $349,109,921 | 8,381,991 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $167,018,174 | 5,807,308 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $231,137,453 | 6,891,397 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $355,382,485 | 6,950,567 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $227,890,206 | 4,459,691 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $206,948,293 | 4,620,413 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $139,099,749 | 2,971,582 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $115,460,833 | 3,245,105 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $108,260,585 | 3,640,235 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $64,902,849 | 3,601,712 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $58,386,546 | 3,635,526 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $51,322,074 | 2,804,485 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $51,712,335 | 2,633,011 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,010,102 | 1,823,598 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,594,538 | 1,029,364 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,406,426 | 1,070,272 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,220,144 | 913,071 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,050,543 | 745,387 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,437,110 | 552,167 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,854,119 | 556,635 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,859,636 | 437,756 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,453,643 | 311,281 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||